Cargando…

Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries

Detalles Bibliográficos
Autores principales:	Gianfrancesco, Milena A, Hyrich, Kimme L, Gossec, Laure, Strangfeld, Anja, Carmona, Loreto, Mateus, Elsa F, Sufka, Paul, Grainger, Rebecca, Wallace, Zachary, Bhana, Suleman, Sirotich, Emily, Liew, Jean, Hausmann, Jonathan S, Costello, Wendy, Robinson, Philip, Machado, Pedro M, Yazdany, Jinoos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162647/ https://www.ncbi.nlm.nih.gov/pubmed/32309814 http://dx.doi.org/10.1016/S2665-9913(20)30095-3

Ejemplares similares

The impact of COVID-19 on rheumatology training—results from the COVID-19 Global Rheumatology Alliance trainee survey
por: Young, Kristen, et al.
Publicado: (2022)

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
por: Strangfeld, Anja, et al.
Publicado: (2021)

Characteristics and Outcomes of People With Gout Hospitalized Due to COVID‐19: Data From the COVID‐19 Global Rheumatology Alliance Physician‐Reported Registry
por: Jatuworapruk, Kanon, et al.
Publicado: (2022)

Association Between Race/Ethnicity and COVID‐19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID‐19 Global Rheumatology Alliance
por: Ugarte‐Gil, Manuel F., et al.
Publicado: (2022)

SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry
por: Liew, Jean, et al.
Publicado: (2022)

Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
por: Yeoh, Su-Ann, et al.
Publicado: (2022)

Rapid Adoption of Telemedicine in Rheumatology Care During the COVID‐19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology Trainees
por: Yeoh, Su‐Ann, et al.
Publicado: (2021)

Omicron variant infection in inflammatory rheumatological conditions – outcomes from a COVID-19 naive population in Aotearoa New Zealand
por: Brooks, Jonathon, et al.
Publicado: (2023)

The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
por: Robinson, Philip C., et al.
Publicado: (2020)

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study
por: Sattui, Sebastian E, et al.
Publicado: (2021)

Development of a Prediction Model for COVID‐19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry
por: Izadi, Zara, et al.
Publicado: (2022)

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries
por: Machado, Pedro M, et al.
Publicado: (2023)

COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: Putman, Michael, et al.
Publicado: (2022)

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: Sattui, Sebastian Eduardo, et al.
Publicado: (2021)

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: DiIorio, Michael, et al.
Publicado: (2022)

The racial/ethnic and sociocultural aspects of the pandemic in rheumatology
por: Taylor, Tiffany, et al.
Publicado: (2021)

Initial data from the COVID-19 Global Rheumatology Alliance provider registries – Authors' reply
por: Gianfrancesco, Milena A
Publicado: (2020)

Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases
por: Hausmann, Jonathan S, et al.
Publicado: (2021)

Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study
por: Izadi, Zara, et al.
Publicado: (2022)

Predictors of hospitalization in patients with rheumatic disease and COVID-19 in Ireland: data from the COVID-19 global rheumatology alliance registry
por: Conway, Richard, et al.
Publicado: (2021)

Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry
por: Conway, Richard, et al.
Publicado: (2022)

COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
por: Grainger, Rebecca, et al.
Publicado: (2022)

Initial data from the COVID-19 Global Rheumatology Alliance provider registries
por: Vanjak, Anthony
Publicado: (2020)

Racial and ethnic differences in COVID-19 outcomes: a call to action
por: Robinson, Philip C, et al.
Publicado: (2022)

How COVID-19 is changing rheumatology clinical practice
por: Bonfá, Eloisa, et al.
Publicado: (2020)

P61 SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry
por: Lawson-Tovey, Saskia, et al.
Publicado: (2022)

Removing barriers and disparities in health: lessons from the COVID-19 pandemic
por: Sirotich, Emily, et al.
Publicado: (2020)

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
por: Izadi, Zara, et al.
Publicado: (2021)

Implementation of disease activity measurement for rheumatoid arthritis patients in an academic rheumatology clinic
por: Bays, Alison, et al.
Publicado: (2016)

Epidemiology and treatment of Behçet’s disease in the USA: insights from the Rheumatology Informatics System for Effectiveness (RISE) Registry with a comparison with other published cohorts from endemic regions
por: Hammam, Nevin, et al.
Publicado: (2021)

Factors Associated With Hospitalization and Death After COVID‐19 Diagnosis Among Patients With Rheumatic Disease: An Analysis of Veterans Affairs Data
por: Schmajuk, Gabriela, et al.
Publicado: (2021)

SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry
por: Lawson-Tovey, Saskia, et al.
Publicado: (2022)

Rheumatic disease and COVID-19: epidemiology and outcomes
por: Hyrich, Kimme L., et al.
Publicado: (2020)

The Relationship Between Electronic Health Record System and Performance on Quality Measures in the American College of Rheumatology’s Rheumatology Informatics System for Effectiveness (RISE) Registry: Observational Study
por: Hammam, Nevin, et al.
Publicado: (2021)

Type I interferon, anti-interferon antibodies, and COVID-19
por: Calabrese, Leonard H, et al.
Publicado: (2021)

Inflammatory arthritis in patients with COVID-19
por: Conway, Richard, et al.
Publicado: (2021)

COVID‐19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID‐19 Global Rheumatology Alliance (C19‐GRA) physician registry
por: Abutiban, Fatemah, et al.
Publicado: (2022)

COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis
por: Deodhar, Atul, et al.
Publicado: (2022)

Research priorities in pediatric rheumatology: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) consensus
por: Ota, Sylvia, et al.
Publicado: (2008)

Evaluating the Use of Glucocorticoids Among Belimumab‐Treated Patients With Systemic Lupus Erythematosus in Real‐World Settings Using the Rheumatology Informatics System for Effectiveness Registry
por: Hammam, Nevin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iv7h09ndjeekdm8l1t6qu3vh1h